How should a patient be transitioned from 10 mg of immediate‑release Adderall (mixed amphetamine salts) to a single daily dose of Adderall XR 10 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Transitioning from Immediate-Release to Extended-Release Adderall

Patients taking 10 mg of immediate-release Adderall can be directly switched to Adderall XR 10 mg once daily in the morning, as the total daily dose remains equivalent. 1

Direct Conversion Strategy

The FDA label explicitly states that patients taking divided doses of immediate-release Adderall may be switched to Adderall XR at the same total daily dose taken once daily based on bioequivalence data 1. This means:

  • 10 mg immediate-release Adderall → 10 mg Adderall XR once daily
  • Administer upon awakening
  • Avoid afternoon doses due to insomnia risk

Pharmacokinetic Rationale

The bioequivalence between formulations has been rigorously established. A single 20 mg dose of Adderall XR provides comparable plasma concentration profiles to immediate-release Adderall 10 mg given twice daily (4 hours apart) 2. The extended-release formulation contains immediate-release beads that deliver the first half of the dose upon ingestion, with delayed-release beads releasing approximately 4 hours later 3. This design maintains therapeutic amphetamine levels throughout the day with once-daily dosing.

Time to maximum concentration (Tmax) for Adderall XR is approximately 7 hours compared to 3 hours for immediate-release, providing extended symptom control for approximately 12 hours 1, 4.

Administration Considerations

Adderall XR should be given upon awakening 1. The capsule may be:

  • Swallowed whole, OR
  • Opened and sprinkled on applesauce (consumed immediately without chewing)

Food does not significantly affect absorption extent but delays Tmax by approximately 2.5 hours 1. The sprinkled administration method is bioequivalent to the intact capsule 2.

Titration After Conversion

While the initial conversion is 1:1, subsequent dose adjustments should occur at weekly intervals based on symptom control and tolerability 1. For children (ages 6-12), doses may be adjusted in 5 mg or 10 mg increments, with a maximum of 30 mg/day 1.

Common Pitfalls to Avoid

  • Do not divide the capsule contents—the entire capsule dose must be taken 1
  • Do not give afternoon doses of XR formulation due to insomnia risk 1
  • Monitor for adverse effects including decreased appetite, sleep disturbances, increased blood pressure/heart rate, and irritability 5
  • Periodically reassess the need for continued therapy by interrupting treatment when possible 1

The conversion is straightforward and evidence-based, allowing seamless transition while maintaining therapeutic efficacy throughout the day with improved adherence compared to multiple daily dosing 5.

References

4
Research

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.

Journal of the American Academy of Child and Adolescent Psychiatry, 2003

Related Questions

What Adderall (mixed amphetamine salts) extended‑release dose should replace Adderall IR 10 mg twice daily?
How can I explain to a patient why taking two 5 mg extended‑release (XR) Adderall (mixed amphetamine salts) tablets is not equivalent to one 10 mg XR tablet when the 10 mg XR is unavailable?
What is the recommended dosing schedule and follow‑up plan for initiating Adderall (mixed amphetamine salts) at 10 mg per day for a two‑week period?
Should I switch from 10 mg immediate‑release Adderall (mixed amphetamine salts) to an extended‑release formulation to achieve full‑day symptom control?
What are the differences between Adderall (mixed amphetamine salts) extended‑release and immediate‑release formulations?
In a patient with WHO Group 1 pulmonary arterial hypertension who is on riociguat (Adempas) with only a fair response and is being transitioned to selexipag (Uptravi), should riociguat be continued or weaned off?
What is the recommended oral magnesium dosing and administration for adults and children?
In a patient with heart failure on sacubitril/valsartan, metoprolol, and hydrochlorothiazide who presents with fatigue, occasional vomiting, and wheezing, is fluid overload likely?
What is the recommended daily elemental magnesium intake for Asian adults (women and men) and for Asian children of different age groups?
What bedside tests should be performed for a patient with suspected hypercalcemia?
How should I evaluate and manage a patient with a long history of anxiety and panic disorder who experiences panic attacks as soon as hunger begins?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.